Interestingly, it has been suggested that a CREB-dependent mechanism may cause resistance to BRAF–MEK inhibition in some melanoma patients43 and that NFAT is activated by oncogenic BRAFV600E via canonical MEK/ERK signaling in melanoma cell lines44. Here, MAP2K7 is linked to melanoma.